CING - Cingulate Inc.
6.43
-0.130 -2.022%
Share volume: 348,598
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.14%
PREVIOUS CLOSE
CHG
CHG%
$6.56
-0.13
-0.02%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | |
| Report Date | 05-08-2024 | 08-13-2024 | 11-07-2024 | 03-27-2025 | 05-08-2025 | 11-13-2025 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | nan% | nan% | ||||
| Operating expenses | 2.948 M | 3.206 M | 3.282 M | 6.208 M | 3.706 M | 5.996 M | |
| Selling general and admin | 1.141 M | 1.325 M | 1.854 M | 1.880 M | 1.483 M | 3.147 M | |
| Research and development | 1.807 M | 1.881 M | 1.429 M | 4.329 M | 2.223 M | 2.849 M | |
| Total expenses | 2.948 M | 3.206 M | 3.282 M | 6.208 M | 3.706 M | 5.996 M | |
| 8.75% | 2.37% | 89.16% | -40.31% | 61.79% | |||
| Operating income | -2.948 M | -3.206 M | -3.282 M | -6.208 M | -3.706 M | -5.996 M | |
| Ebit | -2.948 M | -3.206 M | -3.282 M | -6.208 M | -3.706 M | -7.341 M | |
| Pretax income | -2.972 M | -3.210 M | -3.232 M | -6.132 M | -3.803 M | -7.341 M | |
| 7.98% | 0.68% | 89.75% | -37.99% | 93.05% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -2.972 M | -3.210 M | -3.232 M | -6.132 M | -3.803 M | -7.341 M | |
| -7.98% | -0.68% | -89.75% | 37.99% | -93.05% |